Poster Abstract Session:
55. Community and Healthcare Acquired Pneumonia - Epidemiology
Friday, October 21, 2011: 12:15 PM-2:15 PM
Room: Poster Hall B1

Learning Objectives:

-

Target Audience: Academicians

Topical Category: N. Hospital-acquired and surgical infections, infection control, and health outcomes including general public health and health services research

Tracks: Adult ID

Presentations:

359
Distribution of Pathogens in Patients Hospitalized for Community-Acquired Pneumonia: Analysis of Data from US Hospitals, 2006-2009
David Weber, MD, MPH, FIDSA ; Ariel Berger, MPH ; John Edelsberg, MD, MPH ; Xing-Yue Huang, B. Pharm, Ph.D. ; Gerry Oster, Ph.D.

360
Bacteremic Pseudomonas aeruginosa pneumonia: Impact of adequate empirical antibiotic therapy and multidrug-resistance on the mortally using marginal structural model
So-Youn Park, MD ; Song Mi Moon, MD ; Hyun Jung Park, MD ; Yumi Lee, MD ; Sung-Han Kim, MD, PhD ; Sang-Oh Lee, MD ; Yang Soo Kim, MD, PhD ; Jun Hee Woo, MD, PhD ; Sang-Ho Choi, MD, PhD

361
Hospital Acquired Pneumonia in Japan may have better mortality profile than HAP in the United States. A Retrospective study
Kentaro Iwata, MD ; Wataru Igarashi ; Midori Honjo ; Hideaki Oka ; Yuichiro Oba ; Hiroyuki Yoshida ; Goh Ohji, MD, PhD, DTM&H ; Toshihiko Shimada

363
Patients with Characteristics of both CAP and HCAP, an Overlooked Risk Group
Agnar Bjarnason, MD ; Janus F. Gudnason, MD ; Hilmir Asgeirsson, MD ; Kristinn L. Hallgrimsson, MD ; Berglind Kristjansdottir ; Gunnsteinn Haraldsson, PhD ; Olafur Baldursson, MD, PhD ; Karl G. Kristinsson, MD, PhD ; Magnus Gottfredsson, MD, PhD

364
Incidence, Mortality, and Cost of Healthcare-associated and Community Acquired Pneumonia in Medicare Beneficiaries
Cindy Parks Thomas, Ph.D. ; Marian Ryan, Ph.D. ; John Chapman, Ph.D. ; William Stason, MD ; Christopher P. Tompkins, Ph.D. ; Jose A. Suaya, MD, PhD ; Daniel Polsky, Ph.D. ; David M. Mannino, MD ; Donald S. Shepard, Ph.D.

365
Return to Full Productivity in Adults 50 Years and Older After an Episode of Community-Acquired Pneumonia
Kathleen Wyrwich, Ph.D. ; Holly Yu, MSPH ; Reiko Sato, Ph.D. ; David Strutton, Ph.D. ; John Powers, MD

366
Economic Burden Associated with Community-acquired Pneumonia (CAP) Using Medicare 5% Random Sample
Holly Yu, MSPH ; Stephan Dunning, MBA ; Jaime Rubin, MA ; Suying Li, PhD ; Reiko Sato, Ph.D.

367
Comparative Effectiveness of Strategies to Prevent Ventilator-Associated Pneumonia
Westyn Branch-Elliman, MD ; Sharon B. Wright, MD MPH ; Michael D. Howell, MD, MPH

368
Evaluating Healthcare-Associated Pneumonia (HCAP) in Intensive Care: A Retrospective Analysis of 278 Patients
Thomas M. File Jr., MD MSc ; Paula Peyrani, MD ; Kimbal D. Ford, PharmD ; Verna L. Welch, PhD, MPH ; Ernesto G. Scerpella, MD ; Julio Ramirez, MD

369
The Use of Serial Surveillance Endotracheal Aspirates (EA) Cultures for Microbiologic Diagnosis of Ventilator-Associated Respiratory Infections (VARI)
Jana Hudcova, MD ; Yuxiu Lei, Ph.D ; Robin Ruthazer, MPH ; Akmal Sarwar, MD ; Donald Craven, MD, FIDSA

370
Pneumonia in Intensive Care Unit Patients: Incidence, Risk Factors and Outcomes Related to Multidrug-Resistant Organisms
Daniel H. Kett, MD ; Verna L. Welch, PhD, MPH ; Paula Peyrani, MD ; Ernesto G. Scerpella, MD ; Kimbal D. Ford, PharmD ; Julio Ramirez, MD

371
Ventilator-Associated Respiratory Infections [VARI]: A New Model for Treatment, Diagnosis and Prevention
Donald Craven, MD, FIDSA ; Jana Hudcova, MD ; Robin Ruthazer, MPH ; Yuxiu Lei, Ph.D ; Marie Goggin, MT(ASCP)(SM) ; Akmal Sarwar, MD ; Kenneth Wener, MD

372
Analysis of infectious diseases in the aftermath of the 2011 Tohoku earthquake and tsunami: the threat of pneumonia to survivors
Tetsuji Aoyagi, MD, PhD ; Mitsuhiro Yamada, MD, PhD ; Hiroyuki Kunishima, MD, PhD ; Koichi Tokuda, MD, PhD, MPH ; Hisakazu Yano, MD, PhD ; Noriomi Ishibashi, MD ; Masumitsu Hatta, MD, PhD ; Shiro Endo, MD, PhD ; Kazuaki Arai, ICMT, PhD ; Hajime Kanamori, MD, PhD ; Miho Kitagawa ; Yoichi Hirakata, MD, PhD ; Mitsuo Kaku, MD, PhD

CME Credits:

ACPE Credits:

ACPE Number:


Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.